OpenURL Connection Search

Select item for more details and to access through your institution.

Management of elevated blood glucose in type 2 diabetes.
Published in:
Practice Nursing, 2019, v. 30, n. 1, p. 32, doi. 10.12968/pnur.2019.30.1.32
By:
- Holmes, Patrick
Publication type:
Article
Managing problems with medications for type 2 diabetes.
Published in:
Practice Nursing, 2017, v. 28, n. 4, p. 148, doi. 10.12968/pnur.2017.28.4.148
By:
- Morris, David
Publication type:
Article
The link between diabetes and polycystic ovary syndrome.
Published in:
Practice Nursing, 2013, v. 24, n. 3, p. 120, doi. 10.12968/pnur.2013.24.3.120
By:
- Prasad Pothina, Narayana;
- Jennings, Paul
Publication type:
Article
Managing diabetes during the holy month of Ramadan.
Published in:
Practice Nursing, 2012, v. 23, n. 6, p. 302, doi. 10.12968/pnur.2012.23.6.302
By:
- Wisher, Ann Maria
Publication type:
Article
Competition of zinc ion for the [2Fe-2S] cluster binding site in the diabetes drug target protein mitoNEET.
Published in:
BioMetals, 2012, v. 25, n. 6, p. 1177, doi. 10.1007/s10534-012-9580-4
By:
- Tan, Guoqiang;
- Landry, Aaron;
- Dai, Ruili;
- Wang, Li;
- Lu, Jianxin;
- Ding, Huangen
Publication type:
Article
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.
Published in:
Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 103, doi. 10.1002/hup.2517
By:
- Iranpour, Negar;
- Zandifar, Atefeh;
- Farokhnia, Mehdi;
- Goguol, Amirhossein;
- Yekehtaz, Habibeh;
- Khodaie ‐ Ardakani, Mohammad ‐ Reza;
- Salehi, Bahman;
- Esalatmanesh, Sophia;
- Zeionoddini, Atefeh;
- Mohammadinejad, Payam;
- Zeinoddini, Arefeh;
- Akhondzadeh, Shahin
Publication type:
Article
Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes.
Published in:
Acta Diabetologica, 2015, v. 52, n. 6, p. 1083, doi. 10.1007/s00592-015-0792-2
By:
- Li, Renyuan;
- Xu, Wen;
- Luo, Sihui;
- Xu, Haixia;
- Tong, Guoyu;
- Zeng, Longyi;
- Zhu, Dalong;
- Weng, Jianping
Publication type:
Article
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.
Published in:
Acta Diabetologica, 2014, v. 51, n. 5, p. 865, doi. 10.1007/s00592-014-0638-3
By:
- Bi, Yan;
- Zhang, Bing;
- Xu, Wen;
- Yang, Huijie;
- Feng, Wenhuan;
- Li, Cuiliu;
- Tong, Guoyu;
- Li, Ming;
- Wang, Xin;
- Shen, Shanmei;
- Zhu, Bin;
- Weng, Jianping;
- Zhu, Dalong
Publication type:
Article
Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes.
Published in:
Acta Diabetologica, 2014, v. 51, n. 2, p. 185, doi. 10.1007/s00592-013-0457-y
By:
- Arnetz, Lisa;
- Dorkhan, Mozhgan;
- Alvarsson, Michael;
- Brismar, Kerstin;
- Ekberg, Neda
Publication type:
Article
Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms.
Published in:
Acta Diabetologica, 2013, v. 50, n. 2, p. 163, doi. 10.1007/s00592-010-0239-8
By:
- Wang, An-ping;
- Li, Xia;
- Zheng, Ying;
- Liu, Bi-lian;
- Huang, Gan;
- Yan, Xiang;
- Liu, Zhenqi;
- Zhou, Zhiguang
Publication type:
Article
Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes.
Published in:
Acta Diabetologica, 2011, v. 48, n. 4, p. 283, doi. 10.1007/s00592-011-0258-0
By:
- Gianiorio, F.;
- Casu, M.;
- Patrone, V.;
- Egan, C.;
- Murialdo, G.
Publication type:
Article
Comparison of the Effect of Pioglitazone and Metformin on HOMA IR In Patient of Prediabetes.
Published in:
Indian Journal of Basic & Applied Medical Research, 2021, v. 10, n. 3, p. 43, doi. 10.36848/IJBAMR/2020/29215.55575
By:
- Umar, Sayed Asif;
- Bhosle, Deepak;
- bhagat, Abhijeet
Publication type:
Article
Managing Comorbidities in Patients with Chronic Heart Failure: First, Do No Harm.
Published in:
American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 171, doi. 10.1007/s40256-015-0115-6
By:
- DeJongh, Beth;
- Birkeland, Kade;
- Brenner, Michael
Publication type:
Article
Pioglitazone is a Valid Alternative to Rosiglitazone.
Published in:
American Journal of Cardiovascular Drugs, 2011, v. 11, n. 6, p. 357, doi. 10.2165/11595990-000000000-00000
By:
- Derosa, Giuseppe
Publication type:
Article
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials.
Published in:
American Journal of Cardiovascular Drugs, 2011, v. 11, n. 2, p. 115, doi. 10.2165/11587580-000000000-00000
By:
- Hernandez, Adrian V.;
- Usmani, Ali;
- Rajamanickam, Anitha;
- Moheet, A.
Publication type:
Article
Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
Published in:
Neuropathology, 2010, v. 30, n. 4, p. 353, doi. 10.1111/j.1440-1789.2009.01078.x
By:
- Shibata, Noriyuki;
- Yamamoto, Tomoko;
- Hiroi, Atsuko;
- Omi, Yoko;
- Kato, Yoichiro;
- Kobayashi, Makio
Publication type:
Article
Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes.
Published in:
Scientific Reports, 2015, p. 10722, doi. 10.1038/srep10722
By:
- Matsumoto, Yasuhiko;
- Ishii, Masaki;
- Hayashi, Yohei;
- Miyazaki, Shinya;
- Sugita, Takuya;
- Sumiya, Eriko;
- Sekimizu, Kazuhisa
Publication type:
Article
Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.
Published in:
Cells (2073-4409), 2021, v. 10, n. 11, p. 3044, doi. 10.3390/cells10113044
By:
- Liu, Szu-Yu;
- Huang, Chia-Chang;
- Huang, Shiang-Fen;
- Liao, Tsai-Ling;
- Kuo, Nai-Rong;
- Yang, Ying-Ying;
- Li, Tzu-Hao;
- Liu, Chih-Wei;
- Hou, Ming-Chih;
- Lin, Han-Chieh
Publication type:
Article
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'.
Published in:
Diabetic Medicine, 2022, v. 39, n. 10, p. 1, doi. 10.1111/dme.14912
Publication type:
Article
Pioglitazone and bladder cancer: improving research methods.
Published in:
2020
By:
- Ripamonti, E.;
- Azoulay, L.;
- Abrahamowicz, M.;
- Platt, R. W.;
- Suissa, S.
Publication type:
Letter to the Editor
More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
Published in:
Diabetic Medicine, 2020, v. 37, n. 2, p. 194, doi. 10.1111/dme.14179
By:
- Dankner, R.;
- Roth, J.
Publication type:
Article
Pioglitazone: inexpensive; very effective at reducing HbA<sub>1c</sub>; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit.
Published in:
Diabetic Medicine, 2019, v. 36, n. 9, p. 1185, doi. 10.1111/dme.14053
By:
- Ryder, Robert E. J.;
- DeFronzo, Ralph A.
Publication type:
Article
A systematic review of observational studies of the association between pioglitazone use and bladder cancer.
Published in:
Diabetic Medicine, 2019, v. 36, n. 1, p. 22, doi. 10.1111/dme.13854
By:
- Ripamonti, E.;
- Azoulay, L.;
- Abrahamowicz, M.;
- Platt, R.W.;
- Suissa, S.
Publication type:
Article
Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia.
Published in:
Diabetic Medicine, 2017, v. 34, n. 9, p. 1322, doi. 10.1111/dme.13393
By:
- Ray, S.;
- Mukherjee, J. J.
Publication type:
Article
Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.
Published in:
Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125
By:
- Kumar, S.;
- Jang, H. C.;
- Demirağ, N. G.;
- Skjøth, T. V.;
- Endahl, L.;
- Bode, B.
Publication type:
Article
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA<sub>1c</sub> and high incidence of hypoglycaemia.
Published in:
Diabetic Medicine, 2016, v. 33, n. 9, p. e17, doi. 10.1111/dme.12988
By:
- Oei, E.;
- Samad, N.;
- Visser, A.;
- Chowdhury, T. A.;
- Fan, S. L.
Publication type:
Article
Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes.
Published in:
Diabetic Medicine, 2016, v. 33, n. 7, p. 926, doi. 10.1111/dme.13041
By:
- Durán‐Garcia, S.;
- Lee, J.;
- Yki‐Järvinen, H.;
- Rosenstock, J.;
- Hehnke, U.;
- Thiemann, S.;
- Patel, S.;
- Woerle, H.‐J.
Publication type:
Article
NICE guidelines for Type 2 diabetes: revised but still not fit for purpose.
Published in:
Diabetic Medicine, 2015, v. 32, n. 11, p. 1398, doi. 10.1111/dme.12952
By:
- O'Hare, J. P.;
- Hanif, W.;
- Millar‐Jones, D.;
- Bain, S.;
- Hicks, D.;
- Leslie, R. D.;
- Barnett, A. H.
Publication type:
Article
Pioglitazone: reports of its death are greatly exaggerated.
Published in:
Diabetic Medicine, 2015, v. 32, n. 4, p. e9, doi. 10.1111/dme.12736
By:
- Ryder, R. E. J.
Publication type:
Article
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter.
Published in:
Diabetic Medicine, 2015, v. 32, n. 4, p. 438, doi. 10.1111/dme.12703
By:
- Ryder, R. E. J.
Publication type:
Article
Pioglitazone: are rumours of its death exaggerated?
Published in:
Diabetic Medicine, 2015, v. 32, n. 4, p. 431, doi. 10.1111/dme.12708
By:
- Gale, E. A. M.
Publication type:
Article
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.
Published in:
Diabetic Medicine, 2015, v. 32, n. 3, p. 305, doi. 10.1111/dme.12627
By:
- Ryder, R. E. J.
Publication type:
Article
Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
Published in:
Diabetic Medicine, 2014, v. 31, n. 12, p. 1505, doi. 10.1111/dme.12495
By:
- Bajaj, M.;
- Gilman, R.;
- Patel, S.;
- Kempthorne‐Rawson, J.;
- Lewis‐D'Agostino, D.;
- Woerle, H.‐J.
Publication type:
Article
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes.
Published in:
Diabetic Medicine, 2014, v. 31, n. 11, p. 1341, doi. 10.1111/dme.12481
By:
- Lin, K. ‐ D.;
- Lee, M. ‐ Y.;
- Feng, C. ‐ C.;
- Chen, B. K.;
- Yu, M. ‐ L.;
- Shin, S. ‐ J.
Publication type:
Article
Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.
Published in:
Diabetic Medicine, 2013, v. 30, n. 9, p. 1026, doi. 10.1111/dme.12144
By:
- Ferwana, M.;
- Firwana, B.;
- Hasan, R.;
- Al ‐ Mallah, M. H.;
- Kim, S.;
- Montori, V. M.;
- Murad, M. H.
Publication type:
Article
A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy.
Published in:
Diabetic Medicine, 2013, v. 30, n. 7, p. 846, doi. 10.1111/dme.12158
By:
- Derosa, G.;
- Cicero, A. F. G.;
- Franzetti, I. G.;
- Querci, F.;
- Carbone, A.;
- Piccinni, M. N.;
- D'Angelo, A.;
- Fogari, E.;
- Maffioli, P.
Publication type:
Article
Potential role of non-insulin adjunct therapy in Type 1 diabetes.
Published in:
Diabetic Medicine, 2013, v. 30, n. 2, p. 179, doi. 10.1111/j.1464-5491.2012.03744.x
By:
- George, P.;
- McCrimmon, R. J.
Publication type:
Article
Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance.
Published in:
Diabetic Medicine, 2012, v. 29, n. 3, p. 359, doi. 10.1111/j.1464-5491.2011.03458.x
By:
- Yang, H.-B.;
- Zhao, X.-Y.;
- Zhang, J.-Y.;
- Du, Y.-Y.;
- Wang, X.-F.
Publication type:
Article
Pioglitazone and bladder cancer.
Published in:
BJU International, 2016, v. 118, n. 1, p. 16, doi. 10.1111/bju.13352
By:
- Warren, Hannah;
- Raison, Nicholas;
- Dasgupta, Prokar
Publication type:
Article
Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats.
Published in:
Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00545
By:
- Li Sun;
- Quan Yuan;
- Tianhua Xu;
- Li Yao;
- Jiangmin Feng;
- Jianfei Ma;
- Lining Wang;
- Changlong Lu;
- Danan Wang
Publication type:
Article
Pioglitazone, a Peroxisome Proliferator-Activated Receptor-g Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes.
Published in:
Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.884237
By:
- Nascimento, Maurício T.;
- Cordeiro, Ravena S. O.;
- Abreu, Cayo;
- Santos, Camila P.;
- Peixoto, Fábio;
- Duarte, Gabriela A.;
- Cardoso, Thiago;
- de Oliveira, Camila I.;
- Carvalho, Edgar M.;
- Carvalho, Lucas P.
Publication type:
Article
Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3137, doi. 10.1111/dom.15641
By:
- Yang, Min;
- Yue, Han;
- Xu, Qinqin;
- Shao, Shiying;
- Chen, Yong
Publication type:
Article
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2969, doi. 10.1111/dom.15622
By:
- Chang, Ming‐Ling;
- Tai, Jennifer;
- Cheng, Jur‐Shan;
- Chen, Wei‐Ting;
- Yang, Sien‐Sing;
- Chiu, Cheng‐Hsun;
- Chien, Rong‐Nan
Publication type:
Article
Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2606, doi. 10.1111/dom.15576
By:
- Anson, Matthew;
- Henney, Alex E.;
- Zhao, Sizheng S.;
- Ibarburu, Gema H.;
- Lip, Gregory Y. H.;
- Cuthbertson, Daniel J.;
- Nabrdalik, Katarzyna;
- Alam, Uazman
Publication type:
Article
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2188, doi. 10.1111/dom.15526
By:
- Lim, Soo;
- Lee, Seung‐Hwan;
- Min, Kyung‐Wan;
- Lee, Chang Beom;
- Kim, Sang Yong;
- Yoo, Hye Jin;
- Kim, Nan Hee;
- Kim, Jae Hyeon;
- Oh, Seungjoon;
- Won, Jong Chul;
- Kwon, Hyuk Sang;
- Kim, Mi Kyung;
- Park, Jung Hwan;
- Jeong, In‐Kyung;
- Kim, Sungrae
Publication type:
Article
In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3093, doi. 10.1111/dom.15222
By:
- Bell, David S. H.;
- Jerkins, Terri
Publication type:
Article
Validation of a diet‐induced Macaca fascicularis model of non‐alcoholic steatohepatitis with dietary and pioglitazone interventions.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1068, doi. 10.1111/dom.14955
By:
- Camacho, Raul C.;
- Polidori, David;
- Chen, Tao;
- Chen, Bin;
- Hsu, Helen Han;
- Gao, Bin;
- Marella, Mathieu;
- Lubomirski, Mariusz;
- Beavers, Traymon;
- Cabrera, Javier;
- Wong, Peggy;
- Nawrocki, Andrea R.
Publication type:
Article
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1112, doi. 10.1111/dom.14936
By:
- Bril, Fernando;
- Kalavalapalli, Srilaxmi;
- Lomonaco, Romina;
- Cusi, Kenneth
Publication type:
Article
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 426, doi. 10.1111/dom.14885
By:
- Moody, Alexander J.;
- Molina‐Wilkins, Marjorie;
- Clarke, Geoffrey D.;
- Merovci, Aurora;
- Solis‐Herrera, Carolina;
- Cersosimo, Eugenio;
- Chilton, Robert J.;
- Iozzo, Patricia;
- Gastaldelli, Amalia;
- Abdul‐Ghani, Muhammad;
- DeFronzo, Ralph A.
Publication type:
Article
Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1150, doi. 10.1111/dom.14687
By:
- Spence, J. David;
- Viscoli, Catherine;
- Kernan, Walter N.;
- Young, Lawrence H.;
- Furie, Karen;
- DeFronzo, Ralph;
- Abdul‐Ghani, Muhammad;
- Dandona, Paresh;
- Inzucchi, Silvio E.
Publication type:
Article

Found: 913